[1] [4] Published phase 2 trial data (Jastreboff et al., NEJM , 2023) reported dose ranges from 1 mg up to 12 mg weekly, with higher doses associated with greater weight loss but also increased rates of gastrointestinal side effects
First, deficiency is common in gut disease chronic enteropathy and exocrine pancreatic insufficiency impair absorption, so cobalamin must be replaced
The regulatory environment continues to evolve, and patients should stay informed about current availability through their prescribers and pharmacies
As an illustration, the BPC 157 animals exhibited less colitis lesions and advanced anastomosis healing and functioned much better and mostly achieved pre-operative weigh
Robust quality-assurance program with in-house analytical lab performing identity, potency, and sterility testing
Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery